Buy Savara Stock | MSTX Stock Price & Latest News | Public.com
MSTX

Savara

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View Savara (MSTX) stock trends here

    About MSTX

    Savara, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its products include AeroVanc, Molgradex, GM-CSF, and...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.06
    -0.12
    -0.18
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.07

    Actual EPS
    Q1 2021

    Stats

    Market Cap
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High
    1 Year Low
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app